BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20407212)

  • 1. The diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinity.
    Yoshida K; Corper AL; Herro R; Jabri B; Wilson IA; Teyton L
    J Clin Invest; 2010 May; 120(5):1578-90. PubMed ID: 20407212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules.
    Quarsten H; Paulsen G; Johansen BH; Thorpe CJ; Holm A; Buus S; Sollid LM
    Int Immunol; 1998 Aug; 10(8):1229-36. PubMed ID: 9723710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
    Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
    J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder.
    Stratmann T; Apostolopoulos V; Mallet-Designe V; Corper AL; Scott CA; Wilson IA; Kang AS; Teyton L
    J Immunol; 2000 Sep; 165(6):3214-25. PubMed ID: 10975837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes.
    Corper AL; Stratmann T; Apostolopoulos V; Scott CA; Garcia KC; Kang AS; Wilson IA; Teyton L
    Science; 2000 Apr; 288(5465):505-11. PubMed ID: 10775108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The P9 peptide sidechain specificity of I-Ad.
    Bartnes K; Li X; Briand JP; Travers PJ; Hannestad K
    Immunol Lett; 1999 Dec; 70(3):199-202. PubMed ID: 10656674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease.
    Hovhannisyan Z; Weiss A; Martin A; Wiesner M; Tollefsen S; Yoshida K; Ciszewski C; Curran SA; Murray JA; David CS; Sollid LM; Koning F; Teyton L; Jabri B
    Nature; 2008 Nov; 456(7221):534-8. PubMed ID: 19037317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformation of MHC class II I-A(g7) is sensitive to the P9 anchor amino acid in bound peptide.
    Gardiner A; Richards KA; Sant AJ; Arneson LS
    Int Immunol; 2007 Sep; 19(9):1103-13. PubMed ID: 17855434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of a specific self-peptide: self-MHC class II complex is critical for positive selection of thymocytes expressing the D10 TCR.
    Dao T; Blander JM; Sant'Angelo DB
    J Immunol; 2003 Jan; 170(1):48-54. PubMed ID: 12496382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
    Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
    J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations.
    Bhayani H; Paterson Y
    J Exp Med; 1989 Nov; 170(5):1609-25. PubMed ID: 2553848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of the diabetes-associated mouse MHC class II protein, I-Ag7.
    Reizis B; Eisenstein M; Bocková J; Könen-Waisman S; Mor F; Elias D; Cohen IR
    Int Immunol; 1997 Jan; 9(1):43-51. PubMed ID: 9043946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC class II Ab diabetogenic residue 57 Asp/non-Asp dimorphism influences T-cell recognition and selection.
    Antoniou AN; Elliott J; Rosmarakis E; Dyson PJ
    Immunogenetics; 1998; 47(3):218-25. PubMed ID: 9435340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
    Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
    J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of I-Ag7 beta chain in peptide binding and antigen recognition by T cells.
    Kanagawa O; Shimizu J; Unanue ER
    Int Immunol; 1997 Oct; 9(10):1523-6. PubMed ID: 9352357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Position β57 of I-A
    Gioia L; Holt M; Costanzo A; Sharma S; Abe B; Kain L; Nakayama M; Wan X; Su A; Mathews C; Chen YG; Unanue E; Teyton L
    Sci Immunol; 2019 Aug; 4(38):. PubMed ID: 31471352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MHC class II molecule I-Ag7 exists in alternate conformations that are peptide dependent.
    Arneson LS; Peterson M; Sant AJ
    J Immunol; 2000 Aug; 165(4):2059-67. PubMed ID: 10925290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activation threshold of CD4+ T cells is defined by TCR/peptide-MHC class II interactions in the thymic medulla.
    Stephen TL; Tikhonova A; Riberdy JM; Laufer TM
    J Immunol; 2009 Nov; 183(9):5554-62. PubMed ID: 19843939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Promiscuous T cell hybridoma derived from NOD mouse].
    Katoh M
    Hokkaido Igaku Zasshi; 1995 Mar; 70(2):275-88. PubMed ID: 7774880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-dependent peptide binding properties of the type I diabetes-associated I-Ag7 molecule: rapid release of CLIP at an endosomal pH.
    Hausmann DH; Yu B; Hausmann S; Wucherpfennig KW
    J Exp Med; 1999 Jun; 189(11):1723-34. PubMed ID: 10359576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.